Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
3-D Matrix is a global medical technology company pioneering the use of self-assembling peptide technology to improve patient outcomes across multiple surgical specialties. Our flagship products, PuraStat and PuraGel, are built on the RADA16 peptide platform and are used by physicians worldwide in gastrointestinal, ENT, and emerging specialty applications. We are a fast-moving, science-driven company with a growing global footprint and a bold pipeline of new clinical opportunities.
The Emerging Markets Development Executive exists to win the hardest battles. While our commercial sales force executes platform selling across established GI and ENT indications, the EMDE team is a separate, elite unit tasked with proving that the self-assembling peptide platform technology can win in entirely new markets: oral surgery, dermatology, dental, oral mucositis, and post-radiation disease. These are markets where we have no established playbook, no existing accounts, and entrenched competitors. You are building from zero.
This is not a traditional sales role. Success is measured by strategic milestones: first competitive displacements, KOL development, clinical case generation, and the creation of a commercial playbook that the broader sales organization can use to scale. You are proving market viability, not executing an existing plan.